Abelson JL. Curtis GC. Uhde TW.
Twenty-four hour growth hormone secretion in patients with panic
disorder. 2005 Jan. Psychoneuroendocrinology. 30(1):72-9.
National
Center for Research Resources
National
Institute of Mental Health
|
|
Phan KL. Fitzgerald DA. Nathan PJ. Moore GJ. Uhde TW. Tancer ME.
Neural substrates for voluntary suppression of negative affect: a
functional magnetic resonance imaging study. 2005 Feb 1. Biol
Psychiatry. 57(3):210-9.
|
|
Brown TM. Uhde TW.
Sleep panic attacks: a micro-movement analysis. 2003. Depress
Anxiety. 18(4):214-20.
|
|
Singareddy R. Moin A. Spurlock L. Merritt-Davis O. Uhde TW.
Skin picking and sleep disturbances: relationship to anxiety and need
for research. 2003. Depress Anxiety. 18(4):228-32.
|
|
Uhde TW.
Genetics and brain function: implications for the treatment of anxiety.
2000 Dec 15. Biol Psychiatry. 48(12):1142-3.
|
|
Nordahl TE. Stein MB. Benkelfat C. Semple WE. Andreason P. Zametkin
A. Uhde TW. Cohen RM.
Regional cerebral metabolic asymmetries replicated in an independent
group of patients with panic disorders. 1998 Nov 15. Biol
Psychiatry. 44(10):998-1006.
|
|
Gurguis GN. Uhde TW.
The relationship between plasma MHPG and NE: employing regression models
in estimating centrally derived MHPG and peripheral NE turnover rate in
panic disorder. 1998 Jan-Feb. J Psychiatr Res. 32(1):11-7.
|
|
McCann UD. Slate SO. Geraci M. Roscow-Terrill D. Uhde TW.
A
comparison of the effects of intravenous pentagastrin on patients with
social phobia, panic disorder and healthy controls. 1997 Mar.
Neuropsychopharmacology. 16(3):229-37.
|
|
Gurguis GN. Vitton BJ. Uhde TW.
Behavioral, sympathetic and adrenocortical responses to yohimbine in
panic disorder patients and normal controls. 1997 Jun 16.
Psychiatry Res. 71(1):27-39.
|
|
Tancer ME. Uhde TW.
Role of serotonin drugs in the treatment of social phobia. 1997.
J Clin Psychiatry. 58 Suppl 5:50-4.
|
|
Lin AS. Uhde TW. Slate SO. McCann UD.
Effects of intravenous caffeine administered to healthy males during
sleep. 1997. Depress Anxiety. 5(1):21-8.
|
|
Scupi BS. Benson BE. Brown LB. Uhde TW.
Rapid onset: a valid panic disorder criterion? 1997. Depress
Anxiety. 5(3):121-6.
|
|
Uhde TW.
What looks good and is good for you? The Journal Depression and Anxiety.
1996. Anxiety. 2(6):255.
|
|
Black B. Uhde TW.
Psychiatric characteristics of children with selective mutism: a pilot
study. 1995 Jul. J Am Acad Child Adolesc Psychiatry.
34(7):847-56.
|
|
Black B. Uhde TW.
Treatment of elective mutism with fluoxetine: a double-blind,
placebo-controlled study. 1994 Sep. J Am Acad Child Adolesc
Psychiatry. 33(7):1000-6.
|
|
Cannon RO. Quyyumi AA. Mincemoyer R. Stine AM. Gracely RH. Smith WB.
Geraci MF. Black BC. Uhde TW. Waclawiw MA. et al.
Imipramine in patients with chest pain despite normal coronary
angiograms. 1994 May 19. N Engl J Med. 330(20):1411-7.
|
|
Brown TM. Black B. Uhde TW.
The sleep architecture of social phobia. 1994 Mar 15. Biol
Psychiatry. 35(6):420-1.
|
|
Uhde TW. Tancer ME. Gelernter CS. Vittone BJ.
Normal urinary free cortisol and postdexamethasone cortisol in social
phobia: comparison to normal volunteers. 1994 Mar. J Affect
Disord. 30(3):155-61.
|
|
Uhde TW.
Anxiety and growth disturbance: is there a connection? A review of
biological studies in social phobia. 1994 Jun. J Clin Psychiatry.
55 Suppl:17-27.
|
Steinberg SA. Klein E. Killens RL. Uhde TW.
Inherited deafness among nervous pointer dogs. 1994 Jan-Feb. J
Hered. 85(1):56-9.
National
Center for Research Resources
|
|
George MS. Malloy LC. Slate SO. Uhde TW.
Pilot MRI study of brain size in nervous pointer dogs. 1994-95.
Anxiety. 1(3):129-33.
|
|
Tancer ME. Stein MB. Uhde TW.
Lactic acid response to caffeine in panic disorder: comparison with
social phobics and normal controls. 1994-95. Anxiety.
1(3):138-40.
|
|
Nickell PV. Uhde TW.
Dose-response effects of intravenous caffeine in normal volunteers.
1994-95. Anxiety. 1(4):161-8.
|
|
McCann UD. Slate SO. Geraci M. Uhde TW.
Peptides and anxiety: a dose-response evaluation of pentagastrin in
healthy volunteers. 1994-95. Anxiety. 1(6):258-67.
|
|
Uhde TW. Malloy LC. Benson BB.
Growth hormone response to clonidine in the nervous pointer dog model of
anxiety. 1994. Anxiety. 1(2):45-9.
|
|
Tancer ME. Stein MB. Uhde TW.
Growth hormone response to intravenous clonidine in social phobia:
comparison to patients with panic disorder and healthy volunteers.
1993 Nov 1. Biol Psychiatry. 34(9):591-5.
|
|
Tancer ME. Stein MB. Black B. Uhde TW.
Blunted growth hormone responses to growth hormone-releasing factor and
to clonidine in panic disorder. 1993 Feb. Am J Psychiatry.
150(2):336-7.
|
|
Stein MB. Black B. Brown TM. Uhde TW.
Lack of efficacy of the adenosine reuptake inhibitor dipyridamole in the
treatment of anxiety disorders. 1993 Apr 15-May 1. Biol
Psychiatry. 33(8-9):647-50.
|
|
Uhde TW. Malloy LC. Slate SO.
Fearful behavior, body size, and serum IGF-I levels in nervous and
normal pointer dogs. 1992 Sep. Pharmacol Biochem Behav.
43(1):263-9.
|
|
Black B. Uhde TW.
Acute dystonia and fluoxetine. 1992 Sep. J Clin Psychiatry.
53(9):327.
|
|
Scupi BS. Maser JD. Uhde TW.
The National Institute of Mental Health Panic Questionnaire. An
instrument for assessing clinical characteristics of panic disorder.
1992 Sep. J Nerv Ment Dis. 180(9):566-72.
|
|
Geraci MF. Uhde TW.
Diurnal rhythms and symptom severity in panic disorder. A preliminary
study of 24-hour changes in panic attacks, generalised anxiety, and
avoidance behaviour. 1992 Oct. Br J Psychiatry. 161:512-6.
|
|
Black B. Uhde TW.
Elective mutism as a variant of social phobia. 1992 Nov. J Am
Acad Child Adolesc Psychiatry. 31(6):1090-4.
|
Gelernter CS. Stein MB. Tancer ME. Uhde TW.
An examination of syndromal validity and diagnostic subtypes in social
phobia and panic disorder. 1992 Jan. J Clin Psychiatry.
53(1):23-7.
National
Institute of Mental Health
|
|
Rao SM. Devinsky O. Grafman J. Stein M. Usman M. Uhde TW. Theodore
WH.
Viscosity and social cohesion in temporal lobe epilepsy. 1992 Feb.
J Neurol Neurosurg Psychiatry. 55(2):149-52.
|
|
Uhde TW. Tancer ME. Rubinow DR. Roscow DB. Boulenger JP. Vittone B.
Gurguis G. Geraci M. Black B. Post RM.
Evidence for hypothalamo-growth hormone dysfunction in panic disorder:
profile of growth hormone (GH) responses to clonidine, yohimbine,
caffeine, glucose, GRF and TRH in panic disorder patients versus healthy
volunteers. 1992 Feb. Neuropsychopharmacology. 6(2):101-18.
|
|
Newman F. Stein MB. Trettau JR. Coppola R. Uhde TW.
Quantitative electroencephalographic effects of caffeine in panic
disorder. 1992 Aug. Psychiatry Res. 45(2):105-13.
|
|
Black B. Uhde TW. Tancer ME.
Fluoxetine for the treatment of social phobia. 1992 Aug. J Clin
Psychopharmacol. 12(4):293-5.
|
|
Stein MB. Tancer ME. Uhde TW.
Heart rate and plasma norepinephrine responsivity to orthostatic
challenge in anxiety disorders. Comparison of patients with panic
disorder and social phobia and normal control subjects. 1992 Apr.
Arch Gen Psychiatry. 49(4):311-7.
|
|
Gurguis GN. Mefford IN. Uhde TW.
Hypothalamic-pituitary-adrenocortical activity in panic disorder:
relationship to plasma catecholamine metabolites. 1991 Sep 1.
Biol Psychiatry. 30(5):502-6.
|
Gelernter CS. Uhde TW. Cimbolic P. Arnkoff DB. Vittone BJ. Tancer
ME. Bartko JJ.
Cognitive-behavioral and pharmacological treatments of social phobia. A
controlled study. 1991 Oct. Arch Gen Psychiatry.
48(10):938-45.
National
Institute of Mental Health
|
|
Klein E. Zohar J. Geraci MF. Murphy DL. Uhde TW.
Anxiogenic effects of m-CPP in patients with panic disorder: comparison
to caffeine's anxiogenic effects. 1991 Nov 15. Biol Psychiatry.
30(10):973-84.
|
|
Uhde TW. Tancer ME. Black B. Brown TM.
Phenomenology and neurobiology of social phobia: comparison with panic
disorder. 1991 Nov. J Clin Psychiatry. 52 Suppl:31-40.
|
|
Stein MB. Muir-Nash J. Uhde TW.
The QKd interval in panic disorder: an assessment of end-organ thyroid
hormone responsivity. 1991 Jun 15. Biol Psychiatry.
29(12):1209-14.
|
|
Stein MB. Uhde TW.
Endocrine, cardiovascular, and behavioral effects of intravenous
protirelin in patients with panic disorder. 1991 Feb. Arch Gen
Psychiatry. 48(2):148-56.
|
|
Sklare DA. Stein MB. Pikus AM. Uhde TW.
Dysequilibrium and audiovestibular function in panic disorder: symptom
profiles and test findings. 1990 Sep. Am J Otol.
11(5):338-41.
|
|
Stein MB. Tancer ME. Gelernter CS. Vittone BJ. Uhde TW.
Major depression in patients with social phobia. 1990 May. Am J
Psychiatry. 147(5):637-9.
|
|
Tancer ME. Stein MB. Uhde TW.
Paradoxical growth-hormone responses to thyrotropin-releasing hormone in
panic disorder. 1990 Jun 1. Biol Psychiatry. 27(11):1227-30.
|
|
Tancer ME. Stein MB. Bessette BB. Uhde TW.
Behavioral effects of chronic imipramine treatment in genetically
nervous pointer dogs. 1990 Jul. Physiol Behav. 48(1):179-81.
|
|
Tancer ME. Stein MB. Moul DE. Uhde TW.
Normal serum cholesterol in panic disorder. 1990 Jan 1. Biol
Psychiatry. 27(1):99-101.
|
|
Stein MB. Heuser IJ. Juncos JL. Uhde TW.
Anxiety disorders in patients with Parkinson's disease. 1990 Feb.
Am J Psychiatry. 147(2):217-20.
|
|
Stein MB. Uhde TW.
Triiodothyronine potentiation of tricyclic antidepressant treatment in
patients with panic disorder. 1990 Dec 15. Biol Psychiatry.
28(12):1061-4.
|
|
Mellman TA. Uhde TW.
Patients with frequent sleep panic: clinical findings and response to
medication treatment. 1990 Dec. J Clin Psychiatry.
51(12):513-6.
|
|
Gurguis GN. Uhde TW.
Effect of yohimbine on plasma homovanillic acid in panic disorder
patients and normal controls. 1990 Aug 15. Biol Psychiatry.
28(4):292-6.
|
|
Gurguis GN. Klein E. Mefford IN. Uhde TW.
Biogenic amines distribution in the brain of nervous and normal pointer
dogs. A genetic animal model of anxiety. 1990 Aug.
Neuropsychopharmacology. 3(4):297-303.
|
|
Stein MB. Tancer ME. Uhde TW.
Major depression in patients with panic disorder: factors associated
with course and recurrence. 1990 Aug. J Affect Disord.
19(4):287-96.
|
|
Nordahl TE. Semple WE. Gross M. Mellman TA. Stein MB. Goyer P. King
AC. Uhde TW. Cohen RM.
Cerebral glucose metabolic differences in patients with panic disorder.
1990 Aug. Neuropsychopharmacology. 3(4):261-72.
|
|
Tancer ME. Stein MB. Uhde TW.
Effects of thyrotropin-releasing hormone on blood pressure and heart
rate in phobic and panic patients: a pilot study. 1990 Apr 1.
Biol Psychiatry. 27(7):781-3.
|
|
Klein EH. Tomai T. Uhde TW.
Hypothalamo-pituitary-adrenal axis activity in nervous and normal
pointer dogs. 1990 Apr 1. Biol Psychiatry. 27(7):791-4.
|
|
Tancer ME. Stein MB. Uhde TW.
Growth hormone (GH) response to clonidine and growth hormone releasing
factor (GRF) in normal controls. 1990. Psychoneuroendocrinology.
15(4):253-9.
|
|
Stein MB. Uhde TW.
Thyrotropin and prolactin responses to protirelin (TRH) prior to and
during chronic imipramine treatment in patients with panic disorder.
1990. Psychoneuroendocrinology. 15(5-6):381-9.
|
|
Klein E. Geraci M. Uhde TW.
Inefficacy of single-dose nifedipine in the treatment of phobic anxiety.
1990. Isr J Psychiatry Relat Sci. 27(2):119-23.
|
|
Gurguis GN. Uhde TW.
Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth
hormone responses to yohimbine in panic disorder patients and normal
controls. 1990. Psychoneuroendocrinology. 15(3):217-24.
|
|
Mellman TA. Uhde TW.
Sleep panic attacks: new clinical findings and theoretical implications.
1989 Sep. Am J Psychiatry. 146(9):1204-7.
|
|
Stein MB. Schmidt PJ. Rubinow DR. Uhde TW.
Panic disorder and the menstrual cycle: panic disorder patients, healthy
control subjects, and patients with premenstrual syndrome. 1989 Oct.
Am J Psychiatry. 146(10):1299-303.
|
|
Stein MB. Uhde TW.
Depersonalization disorder: effects of caffeine and response to
pharmacotherapy. 1989 Jul. Biol Psychiatry. 26(3):315-20.
|
|
Uhde TW. Stein MB. Vittone BJ. Siever LJ. Boulenger JP. Klein E.
Mellman TA.
Behavioral and physiologic effects of short-term and long-term
administration of clonidine in panic disorder. 1989 Feb. Arch Gen
Psychiatry. 46(2):170-7.
|
|
Stein MB. Shea CA. Uhde TW.
Social phobic symptoms in patients with panic disorder: practical and
theoretical implications. 1989 Feb. Am J Psychiatry.
146(2):235-8.
|
|
Stein MB. Uhde TW.
Autoimmune thyroiditis and panic disorder. 1989 Feb. Am J
Psychiatry. 146(2):259-60.
|
|
Mellman TA. Uhde TW.
Electroencephalographic sleep in panic disorder. A focus on
sleep-related panic attacks. 1989 Feb. Arch Gen Psychiatry.
46(2):178-84.
|
|
Stein MB. Uhde TW.
Infrequent occurrence of EEG abnormalities in panic disorder. 1989
Apr. Am J Psychiatry. 146(4):517-20.
|
|
Post RM. Rubinow DR. Uhde TW. Roy-Byrne PP. Linnoila M. Rosoff A.
Cowdry R.
Dysphoric mania. Clinical and biological correlates. 1989 Apr.
Arch Gen Psychiatry. 46(4):353-8.
|
|
Uhde TW. Stein MB. Post RM.
Lack of efficacy of carbamazepine in the treatment of panic disorder.
1988 Sep. Am J Psychiatry. 145(9):1104-9.
|
|
Roy-Byrne PP. Risch SC. Uhde TW.
Neuroendocrine effects of diazepam in normal subjects following brief
painful stress. 1988 Oct. J Clin Psychopharmacol. 8(5):331-5.
|
|
Stein MB. Uhde TW.
Routine screening of thyroid indices in patients with panic attacks.
1988 May. J Clin Psychiatry. 49(5):204-5.
|
|
Uhde TW. Joffe RT. Jimerson DC. Post RM.
Normal urinary free cortisol and plasma MHPG in panic disorder: clinical
and theoretical implications. 1988 Mar 15. Biol Psychiatry.
23(6):575-85.
|
|
Klein E. Uhde TW.
24-hour motor activity in genetically nervous and normal pointer dogs.
1988 Mar 1. Biol Psychiatry. 23(5):523-7.
|
|
Roy-Byrne PP. Post RM. Kellner CH. Joffe RT. Uhde TW.
Ventricular-brain ratio and life course of illness in patients with
affective disorder. 1988 Mar. Psychiatry Res. 23(3):277-84.
|
|
Stein MB. Uhde TW.
Panic disorder and major depression. A tale of two syndromes. 1988
Jun. Psychiatr Clin North Am. 11(2):441-61.
|
|
Stein MB. Uhde TW.
Thyroid indices in panic disorder. 1988 Jun. Am J Psychiatry.
145(6):745-7.
|
|
Stein MB. Uhde TW.
Cortisol response to clonidine in panic disorder: comparison with
depressed patients and normal controls. 1988 Jul. Biol Psychiatry.
24(3):322-30.
|
|
Post RM. Roy-Byrne PP. Uhde TW.
Graphic representation of the life course of illness in patients with
affective disorder. 1988 Jul. Am J Psychiatry. 145(7):844-8.
|
|
Roy-Byrne PP. Uhde TW.
Exogenous factors in panic disorder: clinical and research implications.
1988 Feb. J Clin Psychiatry. 49(2):56-61.
|
|
Klein E. Uhde TW.
Controlled study of verapamil for treatment of panic disorder. 1988
Apr. Am J Psychiatry. 145(4):431-4.
|
|
Uhde TW. Tancer ME. Shea CA.
Sexual dysfunction related to alprazolam treatment of social phobia.
1988 Apr. Am J Psychiatry. 145(4):531-2.
|
|
Klein E. Lenox RH. Uhde TW.
Alpha-2 adrenergic receptor binding in platelets and brains of nervous
and normal pointer dogs. 1988. J Psychiatr Res. 22(4):241-7.
|
|
Klein E. Steinberg SA. Weiss SR. Matthews DM. Uhde TW.
The relationship between genetic deafness and fear-related behaviors in
nervous pointer dogs. 1988. Physiol Behav. 43(3):307-12.
|
|
Post RM. Uhde TW. Rubinow DR. Huggins T.
Differential time course of antidepressant effects after sleep
deprivation, ECT, and carbamazepine: clinical and theoretical
implications. 1987 Sep. Psychiatry Res. 22(1):11-9.
|
|
Klein E. Marangos PJ. Montgomery P. Bacher J. Uhde TW.
Adenosine receptor alterations in nervous pointer dogs: a preliminary
report. 1987 Oct. Clin Neuropharmacol. 10(5):462-9.
|
|
Post RM. Uhde TW. Roy-Byrne PP. Joffe RT.
Correlates of antimanic response to carbamazepine. 1987 May.
Psychiatry Res. 21(1):71-83.
|
|
Post RM. DeLisi LE. Holcomb HH. Uhde TW. Cohen R. Buchsbaum MS.
Glucose utilization in the temporal cortex of affectively ill patients:
positron emission tomography. 1987 May. Biol Psychiatry.
22(5):545-53.
|
|
Uhde TW. Kellner CH.
Cerebral ventricular size in panic disorder. 1987 Mar-Apr. J
Affect Disord. 12(2):175-8.
|
|
Boulenger JP. Salem N. Marangos PJ. Uhde TW.
Plasma adenosine levels: measurement in humans and relationship to the
anxiogenic effects of caffeine. 1987 Jul. Psychiatry Res.
21(3):247-55.
|
|
Roy-Byrne P. Geraci M. Uhde TW.
Life events obtained via interview: the effect of time of recall on data
obtained in controls and patients with panic disorder. 1987 Jan-Feb.
J Affect Disord. 12(1):57-62.
|
|
Uhde TW. Berrettini WH. Roy-Byrne PP. Boulenger JP. Post RM.
Platelet [3H]imipramine binding in patients with panic disorder.
1987 Jan. Biol Psychiatry. 22(1):52-8.
|
|
Boulenger JP. Uhde TW.
[Acute anxiety attacks and phobia. Historical aspects and clinical
manifestations of the agoraphobia syndrome] 1987 Feb. Ann Med
Psychol (Paris). 145(2):113-31.
|
Mellman TA. Uhde TW.
Obsessive-compulsive symptoms in panic disorder. 1987 Dec. Am J
Psychiatry. 144(12):1573-6.
National
Institute of Mental Health
|
|
Joffe RT. Uhde TW. Post RM. Minichiello MD.
Motor activity in depressed patients treated with carbamazepine.
1987 Aug. Biol Psychiatry. 22(8):941-6.
|
|
Roy-Byrne PP. Uhde TW. Holcomb H. Thompson K. King AK. Weingartner
H.
Effects of diazepam on cognitive processes in normal subjects. 1987.
Psychopharmacology (Berl). 91(1):30-3.
|
|
Uhde TW. Vittone BJ. Siever LJ. Kaye WH. Post RM.
Blunted growth hormone response to clonidine in panic disorder patients.
1986 Sep. Biol Psychiatry. 21(11):1081-5.
|
|
Roy-Byrne PP. Uhde TW. Post RM.
Effects of one night's sleep deprivation on mood and behavior in panic
disorder. Patients with panic disorder compared with depressed patients
and normal controls. 1986 Sep. Arch Gen Psychiatry.
43(9):895-9.
|
|
Siever LJ. Uhde TW. Jimerson DC. Lake CR. Kopin IJ. Murphy DL.
Indices of noradrenergic output in depression. 1986 Sep.
Psychiatry Res. 19(1):59-73.
|
Mellman TA. Uhde TW.
Withdrawal syndrome with gradual tapering of alprazolam. 1986 Nov.
Am J Psychiatry. 143(11):1464-6.
National
Institute of Mental Health
|
|
Roy-Byrne PP. Geraci M. Uhde TW.
Life events and the onset of panic disorder. 1986 Nov. Am J
Psychiatry. 143(11):1424-7.
|
|
Joffe RT. Post RM. Uhde TW.
Effects of carbamazepine on serum electrolytes in affectively ill
patients. 1986 May. Psychol Med. 16(2):331-5.
|
|
Kafka MS. Nurnberger JI. Siever L. Targum S. Uhde TW. Gershon ES.
Alpha 2-adrenergic receptor function in patients with unipolar and
bipolar affective disorders. 1986 Mar-Apr. J Affect Disord.
10(2):163-9.
|
|
Joffe RT. Post RM. Uhde TW.
Effect of carbamazepine on body weight in affectively ill patients.
1986 Jun. J Clin Psychiatry. 47(6):313-4.
|
|
Lewy AJ. Siever LJ. Uhde TW. Markey SP.
Clonidine reduces plasma melatonin levels. 1986 Jul. J Pharm
Pharmacol. 38(7):555-6.
|
|
Roy-Byrne PP. Uhde TW. Post RM. Gallucci W. Chrousos GP. Gold PW.
The corticotropin-releasing hormone stimulation test in patients with
panic disorder. 1986 Jul. Am J Psychiatry. 143(7):896-9.
|
|
Roy-Byrne PP. Uhde TW. Sack DA. Linnoila M. Post RM.
Plasma HVA and anxiety in patients with panic disorder. 1986 Jul.
Biol Psychiatry. 21(8-9):849-53.
|
|
Post RM. Uhde TW. Roy-Byrne PP. Joffe RT.
Antidepressant effects of carbamazepine. 1986 Jan. Am J
Psychiatry. 143(1):29-34.
|
|
Klein E. Uhde TW. Post RM.
Preliminary evidence for the utility of carbamazepine in alprazolam
withdrawal. 1986 Feb. Am J Psychiatry. 143(2):235-6.
|
|
Roy-Byrne PP. Geraci M. Uhde TW.
Life events and course of illness in patients with panic disorder.
1986 Aug. Am J Psychiatry. 143(8):1033-5.
|
|
Roy-Byrne PP. Uhde TW. Rubinow DR. Post RM.
Reduced TSH and prolactin responses to TRH in patients with panic
disorder. 1986 Apr. Am J Psychiatry. 143(4):503-7.
|
|
Post RM. Rubinow DR. Uhde TW. Ballenger JC. Linnoila M.
Dopaminergic effects of carbamazepine. Relationship to clinical response
in affective illness. 1986 Apr. Arch Gen Psychiatry.
43(4):392-6.
|
|
Post RM. Putnam F. Uhde TW. Weiss SR.
Electroconvulsive therapy as an anticonvulsant. Implications for its
mechanism of action in affective illness. 1986. Ann N Y Acad Sci.
462:376-88.
|
|
Rubinow DR. Post RM. Gold PW. Uhde TW.
Effect of carbamazepine on mean urinary free cortisol excretion in
patients with major affective illness. 1986. Psychopharmacology (Berl).
88(1):115-8.
|
|
Joffe RT. Post RM. Roy-Byrne PP. Uhde TW.
Hematological effects of carbamazepine in patients with affective
illness. 1985 Oct. Am J Psychiatry. 142(10):1196-9.
|
|
Roy-Byrne PP. Bierer LM. Uhde TW.
The dexamethasone suppression test in panic disorder: comparison with
normal controls. 1985 Nov. Biol Psychiatry. 20(11):1237-40.
|
|
Uhde TW. Maser JD.
NIMH report. Current perspectives on panic disorder and agoraphobia.
1985 Nov. Hosp Community Psychiatry. 36(11):1153-4.
|
|
Uhde TW. Bierer LM. Post RM.
Caffeine-induced escape from dexamethasone suppression. 1985 Jul.
Arch Gen Psychiatry. 42(7):737-8.
|
|
Joffe RT. Post RM. Uhde TW.
Lack of pharmacokinetic interaction of carbamazepine with
tranylcypromine. 1985 Jul. Arch Gen Psychiatry. 42(7):738.
|
|
Roy-Byrne P. Uhde TW. Post RM. King AC. Buchsbaum MS.
Normal pain sensitivity in patients with panic disorder. 1985 Jan.
Psychiatry Res. 14(1):77-84.
|
|
Post RM. Uhde TW.
Are the psychotropic effects of carbamazepine in manic-depressive
illness mediated through the limbic system? 1985 Dec. Psychiatr J
Univ Ott. 10(4):205-19.
|
|
Vittone BJ. Uhde TW.
Differential diagnosis and treatment of panic disorder: a medical model
perspective. 1985 Dec. Aust N Z J Psychiatry. 19(4):330-41.
|
|
Joffe RT. Blank DW. Post RM. Uhde TW.
Decreased triiodothyronines in depression: a preliminary report.
1985 Aug. Biol Psychiatry. 20(8):922-5.
|
|
Joffe RT. Rubinow DR. Post RM. Uhde TW.
Relationship between cerebrospinal fluid somatostatin and peripheral
thyroid hormones with carbamazepine treatment. 1985.
Neuropsychobiology. 14(3):115-7.
|
|
Siever LJ. Uhde TW. Insel TR. Kaye WH. Jimerson DC. Lake CR. Kafka
M. Targum S. Murphy DL.
Biological alterations in the primary affective disorders and other
tricyclic-responsive disorders. 1985. Prog Neuropsychopharmacol
Biol Psychiatry. 9(1):15-24.
|
|
Kafka MS. Siever LJ. Nurnberger JI. Uhde TW. Targum S. Cooper DM.
van Kammen DP. Tokola NS.
Platelet alpha-adrenergic receptor function in affective disorders and
schizophrenia. 1985. Psychopharmacol Bull. 21(3):599-602.
|
|
Post RM. Rubinow DR. Uhde TW. Ballenger JC. Lake CR. Linnoila M.
Jimerson DC. Reus V.
Effects of carbamazepine on noradrenergic mechanisms in affectively ill
patients. 1985. Psychopharmacology (Berl). 87(1):59-63.
|
|
Roy-Byrne P. Post RM. Uhde TW. Porcu T. Davis D.
The longitudinal course of recurrent affective illness: life chart data
from research patients at the NIMH. 1985. Acta Psychiatr Scand
Suppl. 317:1-34.
|
|
Roy-Byrne PP. Uhde TW. Gold PW. Rubinow DR. Post RM.
Neuroendocrine abnormalities in panic disorder. 1985.
Psychopharmacol Bull. 21(3):546-50.
|
|
Post RM. Uhde TW.
Carbamazepine in bipolar illness. 1985. Psychopharmacol Bull.
21(1):10-7.
|
|
Uhde TW. Boulenger JP. Roy-Byrne PP. Geraci MF. Vittone BJ. Post RM.
Longitudinal course of panic disorder: clinical and biological
considerations. 1985. Prog Neuropsychopharmacol Biol Psychiatry.
9(1):39-51.
|
|
Roy-Byrne PP. Uhde TW.
Panic disorder and major depression: biological relationships. 1985.
Psychopharmacol Bull. 21(3):551-4.
|
|
Joffe RT. Kellner CH. Post RM. Uhde TW.
Lithium increases platelet count. 1984 Sep 6. N Engl J Med.
311(10):674-5.
|
|
Roy-Byrne PP. Joffe RT. Uhde TW. Post RM.
Approaches to the evaluation and treatment of rapid-cycling affective
illness. 1984 Nov. Br J Psychiatry. 145:543-50.
|
|
Uhde TW. Vittone BJ. Post RM.
Glucose tolerance testing in panic disorder. 1984 Nov. Am J
Psychiatry. 141(11):1461-3.
|
|
Boulenger JP. Uhde TW. Wolff EA. Post RM.
Increased sensitivity to caffeine in patients with panic disorders.
Preliminary evidence. 1984 Nov. Arch Gen Psychiatry.
41(11):1067-71.
|
|
Roy-Byrne P. Uhde TW. Post RM. Joffe RT.
Relationship of response to sleep deprivation and carbamazepine in
depressed patients. 1984 May. Acta Psychiatr Scand.
69(5):379-82.
|
|
Siever LJ. Uhde TW. Jimerson DC. Lake CR. Silberman ER. Post RM.
Murphy DL.
Differential inhibitory noradrenergic responses to clonidine in 25
depressed patients and 25 normal control subjects. 1984 Jun. Am J
Psychiatry. 141(6):733-41.
|
|
Joffe RT. Gold PW. Uhde TW. Post RM.
The effects of carbamazepine on the thyrotropin response to thyrotropin-releasing
hormone. 1984 Jun. Psychiatry Res. 12(2):161-6.
|
|
Uhde TW. Roy-Byrne P. Gillin JC. Mendelson WB. Boulenger JP. Vittone
BJ. Post RM.
The sleep of patients with panic disorder: a preliminary report.
1984 Jul. Psychiatry Res. 12(3):251-9.
|
|
Siever LJ. Uhde TW. Jimerson DC. Post RM. Lake CR. Murphy DL.
Plasma cortisol responses to clonidine in depressed patients and
controls. Evidence for a possible alteration in noradrenergic-neuroendocrine
relationships. 1984 Jan. Arch Gen Psychiatry. 41(1):63-8.
|
|
Siever LJ. Uhde TW.
New studies and perspectives on the noradrenergic receptor system in
depression: effects of the alpha 2-adrenergic agonist clonidine.
1984 Feb. Biol Psychiatry. 19(2):131-56.
|
|
Post RM. Uhde TW.
Carbamazepine and lithium carbonate synergism in mania. 1984 Feb.
Arch Gen Psychiatry. 41(2):210.
|
|
Roy-Byrne PP. Joffe RT. Uhde TW. Post RM.
Carbamazepine and thyroid function in affectively ill patients. Clinical
and theoretical implications. 1984 Dec. Arch Gen Psychiatry.
41(12):1150-3.
|
|
Post RM. Berrettini W. Uhde TW. Kellner C.
Selective response to the anticonvulsant carbamazepine in
manic-depressive illness: a case study. 1984 Aug. J Clin
Psychopharmacol. 4(4):178-85.
|
|
Boulenger JP. Marangos PJ. Patel J. Uhde TW. Post RM.
Central adenosine receptors: possible involvement in the chronic effects
of caffeine. 1984. Psychopharmacol Bull. 20(3):431-5.
|
|
Post RM. Uhde TW. Wolff EA.
Profile of clinical efficacy and side effect of carbamazepine in
psychiatric illness: relationship to blood and CSF levels of
carbamazepine and its -10,11-epoxide metabolite. 1984. Acta
Psychiatr Scand Suppl. 313:104-20.
|
|
Post RM. Uhde TW. Ballenger JC.
The efficacy of carbamazepine in affective illness. 1984. Adv
Biochem Psychopharmacol. 39:421-37.
|
|
Uhde TW. Boulenger JP. Jimerson DC. Post RM.
Caffeine: relationship to human anxiety, plasma MHPG and cortisol.
1984. Psychopharmacol Bull. 20(3):426-30.
|
|
Post RM. Rubinow DR. Uhde TW.
Biochemical mechanisms of action of carbamazepine in affective illness
and epilepsy. 1984. Psychopharmacol Bull. 20(3):585-9.
|
|
Rubinow DR. Post RM. Gold PW. Uhde TW.
Neuroendocrine and peptide effects of carbamazepine: clinical and
mechanistic implications. 1984. Psychopharmacol Bull.
20(3):590-4.
|
|
Uhde TW. Boulenger JP. Post RM. Siever LJ. Vittone BJ. Jimerson DC.
Roy-Byrne PP.
Fear and anxiety: relationship to noradrenergic function. 1984.
Psychopathology. 17 Suppl 3:8-23.
|
|
Roy-Byrne P. Vittone BJ. Uhde TW.
Alprazolam-related hepatotoxicity. 1983 Oct 1. Lancet.
2(8353):786-7.
|
|
Post RM. Uhde TW. Ballenger JC. Chatterji DC. Greene RF. Bunney WE.
Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF.
Relationship to antidepressant response. 1983 Jun. Arch Gen
Psychiatry. 40(6):673-6.
|
|
Siever LJ. Pickar D. Lake CR. Cohen RM. Uhde TW. Murphy DL.
Extreme elevations in plasma norepinephrine associated with decreased
alpha-adrenergic responsiveness in major depressive disorder: two case
reports. 1983 Feb. J Clin Psychopharmacol. 3(1):39-41.
|
|
Siever LJ. Insel TR. Jimerson DC. Lake CR. Uhde TW. Aloi J. Murphy
DL.
Growth hormone response to clonidine in obsessive-compulsive patients.
1983 Feb. Br J Psychiatry. 142:184-7.
|
|
Post RM. Uhde TW. Ballenger JC. Squillace KM.
Prophylactic efficacy of carbamazepine in manic-depressive illness.
1983 Dec. Am J Psychiatry. 140(12):1602-4.
|
|
Uhde TW. Post RM.
Effects of carbamazepine on serum electrolytes: clinical and theoretical
implications. 1983 Apr. J Clin Psychopharmacol. 3(2):103-6.
|
|
Post RM. Uhde TW. Rubinow DR. Ballenger JC. Gold PW.
Biochemical effects of carbamazepine: relationship to its mechanisms of
action in affective illness. 1983. Prog Neuropsychopharmacol Biol
Psychiatry. 7(2-3):263-71.
|
|
Siever LJ. Uhde TW. Jimerson DC. Kafka MS. Lake CR. Targum S. Murphy
DL.
Clinical studies of monoamine receptors in the affective disorders and
receptor changes with antidepressant treatment. 1983. Prog
Neuropsychopharmacol Biol Psychiatry. 7(2-3):249-61.
|
|
Boulenger JP. Uhde TW.
[Treatment of panic attacks] 1983. Encephale. 9(4 Suppl
2):299B-305B.
|
|
Post RM. Uhde TW.
Treatment of mood disorders with antiepileptic medications: clinical and
theoretical implications. 1983. Epilepsia. 24 Suppl
2:S97-108.
|
|
Siever LJ. Uhde TW. Insel TR. Kaye WH. Jimerson DC. Lake CR. Kafka
M. Targum S. Murphy L.
Abnormalities in the primary affective disorders compared to other
tricyclic-responsive disorders. 1983. Psychopharmacol Bull.
19(3):435-6.
|
|
Post RM. Ballenger JC. Uhde TW. Smith C. Rubinow DR. Bunney WE.
Effect of carbamazepine on cyclic nucleotides in CSF of patients with
affective illness. 1982 Sep. Biol Psychiatry. 17(9):1037-45.
|
|
Siever LJ. Uhde TW. Silberman EK. Lake CR. Jimerson DC. Risch SC.
Kalin NH. Murphy DL.
Evaluation of alpha-adrenergic responsiveness to clonidine challenge and
noradrenergic metabolism in the affective disorders and their treatment.
1982 Oct. Psychopharmacol Bull. 18(4):118-9.
|
|
Siever LJ. Uhde TW. Insel TR. Roy BF. Murphy DL.
Growth hormone response to clonidine unchanged by chronic clorgyline
treatment. 1982 Oct. Psychiatry Res. 7(2):139-44.
|
|
Lewy AJ. Wehr TA. Rosenthal NE. Nurnberger JI. Siever LJ. Uhde TW.
Newsome DA. Becker LE. Markey SP. Kopin IJ. Goodwin FK.
Melatonin secretion as a neurobiological "marker" and effects of light
in humans. 1982 Oct. Psychopharmacol Bull. 18(4):127-9.
|
|
Uhde TW. Siever LJ. Post RM. Jimerson DC. Boulenger JP. Buchsbaum
MS.
The relationship of plasma free MHPG to anxiety and psycho-physical pain
in normal volunteers. 1982 Oct. Psychopharmacol Bull.
18(4):129-32.
|
|
Uhde TW. Boulenger JP. Siever LJ. DuPont RL. Post RM.
Animal models of anxiety: implications for research in humans. 1982
Oct. Psychopharmacol Bull. 18(4):47-52.
|
|
Boulenger JP. Uhde TW.
Caffeine consumption and anxiety: preliminary results of a survey
comparing patients with anxiety disorders and normal controls. 1982
Oct. Psychopharmacol Bull. 18(4):53-7.
|
|
Siever LJ. Uhde TW. Murphy DL.
Possible subsensitization of alpha 2-adrenergic receptors by chronic
monoamine oxidase inhibitor treatment in psychiatric patients. 1982
Jun. Psychiatry Res. 6(3):293-302.
|
|
Uhde TW. Redmond DE. Kleber HD.
Psychosis in the opioid addicted patient: assessment and treatment.
1982 Jun. J Clin Psychiatry. 43(6):240-7.
|
|
Boulenger JP. Uhde TW.
[Biochemical aspects of anxiety] 1982 Dec 2. Sem Hop.
58(44):2573-9.
|
|
Post RM. Uhde TW. Putnam FW. Ballenger JC. Berrettini WH.
Kindling and carbamazepine in affective illness. 1982 Dec. J Nerv
Ment Dis. 170(12):717-31.
|
|
Siever LJ. Uhde TW. Silberman EK. Jimerson DC. Aloi JA. Post RM.
Murphy DL.
Growth hormone response to clonidine as a probe of noradrenergic
receptor responsiveness in affective disorder patients and controls.
1982 Apr. Psychiatry Res. 6(2):171-83.
|
|
Post RM. Uhde TW.
Biological relationships between mania and melancholia. 1982.
Encephale. 8(2):213-28.
|
|
Boulenger JP. Uhde TW.
Biological peripheral correlates of anxiety. 1982. Encephale.
8(2):119-30.
|
|
Post RM. Pickar D. Naber D. Ballenger JC. Uhde TW. Bunney WE.
Effect of carbamazepine on CSF opioid activity; relationship to
antidepressant response. 1981 Aug. Psychiatry Res.
5(1):59-66.
|
Uhde TW. Redmond DE. Kleber HD.
Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal
symptoms: a blind inpatient study. 1980 Mar. Psychiatry Res.
2(1):37-47.
National
Institute on Drug Abuse
National
Institute of Mental Health
|
|
Uhde TW. Post RM. Siever LJ. Buchsbaum MS.
Clonidine and psychophysical pain. 1980 Dec 20-27. Lancet.
2(8208-8209):1375.
|
|
Kafka MS. van Kammen DP. Kleinman JE. Nurnberger JI. Siever LJ. Uhde
TW. Polinsky RJ.
Alpha-adrenergic receptor function in schizophrenia, affective disorders
and some neurological diseases. 1980. Commun Psychopharmacol.
4(6):477-86.
|
